Short communication

Scand J Work Environ Health 2025;51(5):449-453    pdf

https://doi.org/10.5271/sjweh.4229 | Published online: 06 May 2025, Issue date: 01 Sep 2025

Detailed mapping of mesothelioma cases in Denmark to identify areas with elevated risk: a nationwide population-based study

by Christensen HS, Jensen RH, Nielsen LH, Bertelsen LD, Teglgaard C, Bønløkke JH, Severinsen MT, Bøgsted M

Objectives Previous studies mapping pleural mesothelioma in Denmark have found that the risk varies between Danish regions. However, evaluating disease risk for such relatively large geographical units ignores any heterogeneity within the unit and can thus diminish more local spikes in risk, missing smaller areas of excess risk. In this study, we examined the distribution of pleural mesothelioma in Denmark on an unprecedented detailed scale, mapping cases to each of the Danish parishes.

Methods We identified individuals diagnosed with pleural mesothelioma between 1990 and 2021 in the Danish Cancer Registry. Considering age- and sex-standardized incidence rate ratios (IRR), we used a conditional autoregressive random effects model to smooth IRR across parishes. Parishes with a smoothed parish-to-national IRR >1.25 or >2.0 with a posterior probability of >95% were flagged as parishes with an excess risk of pleural mesothelioma.

Results We identified 3105 incident cases of pleural mesothelioma in the study period. A total of 74 and 14 parishes were flagged with IRR significantly above 1.25 and 2.0, respectively. These parishes had posterior mean smoothed IRR of 1.82–4.13.

Conclusions We provided a detailed mapping of pleural mesothelioma cases in Denmark and found five distinct areas, each covering several parishes, with a significantly elevated risk. All these areas were in the proximity of previous asbestos-using industries.

This article refers to the following texts of the Journal: 2002;28(6):411-417  2019;45(1):82-89

Mesothelioma is a rare malignancy with a high mortality rate that is most commonly found in the pleura (1). At least 80% of pleural mesothelioma cases can be linked to prior exposure to asbestos (1). Studies mapping mesothelioma cases have identified an elevated risk in areas of previous asbestos-using industries (25). In Denmark, reported differences in incidence rates of mesothelioma across the five Danish regions are presumably also associated with the location of previous asbestos-using industries (68). However, Danish regions are relatively large geographical units, containing 10–30% of the Danish population, and thus more local spikes in risk were diluted. Panou et al (4) did provide a more granular mapping of mesothelioma in Denmark, but only for women in the North Denmark region and with a focus on distinguishing environmentally and occupationally caused cases.

In this paper, we present an unprecedented detailed mapping of all incident pleural mesothelioma cases in Denmark from 1990 to 2021 across the 2141 Danish parishes.

Methods

Danish mesothelioma data

Danish residents diagnosed with pleural mesothelioma between 1 January 1990 and 31 December 2021 were identified using the Danish Cancer Registry, which contains information on all cancer cases in the Danish population since 1943 (9). Diagnoses are coded according to the International Classification of Disease 10th Revision (ICD-10) or converted to ICD-10 if given before ICD-10 were introduced, and morphology is coded according to the International Classification of Diseases for Oncology 3rd Revision (ICD-O-3) (9). We defined pleural mesothelioma cases by either ICD-10 code C45.0 or ICD-10 code C38.4 with ICD-O-3 morphology codes indicating mesothelioma (M9050/3, M9051/3, M9052/3, or M9053/3). Individuals were assigned to a parish based on residential address at diagnosis using the parish division as of 2021; parish populations ranged from 31 to 46 586 individuals with a median population of 1039 individuals.

This study is a register study that does not require informed consent in Denmark. The study has, according to the General Data Protection Regulation (GDPR), been registered in the North Denmark region’s list of register studies (reg. no. F2023-095).

Statistical analysis

We calculated the parish-to-national incidence rate ratio (IRR) using indirect standardization with respect to age and sex, considering seven age groups (≤40, 41–50, 51–60, 61–70, 71–80, 81–90, and >90 years).

As the number of cases per parish is low, the raw incidence rate estimates are unstable. Therefore, we considered a model framework that allowed us to improve estimates of the IRR by borrowing information from neighboring parishes and thus smoothing estimates across parishes. Specifically, using a fully Bayesian setup, we modelled the number of cases by a spatial Poisson distributed generalized linear mixed model with a conditional autoregressive (CAR) correlation structure specified by the Leroux model (10); details can be found in the supplementary material, www.sjweh.fi/article/4229, appendix A. For each parish, we calculated the posterior probability of the smoothed IRR being >1.25 and 2, corresponding to incidence rates elevated by >25% or 100%, respectively, compared to the national rate. Parishes with a posterior probability >95% were flagged as areas with elevated risk of pleural mesothelioma at the specified level. Residual autocorrelation was evaluated using Moran’s I statistic.

Analyses were performed in R (v4.2.2) (11) using the R-package CARBayes (v6.1.1) to fit the spatial model and ape to calculate Moran’s I statistic (v5.8). Code used to run the analysis is exemplified on github.com/CLINDA-AAU/disease_CAR_example.

Results

A total of 3105 Danish residents were diagnosed with pleural mesothelioma between 1 January 1990 and 31 December 2021, corresponding to a national incidence rate of 1.81 per 100 000 person-years. Of these, 2618 (84%) were male and the overall median age at diagnosis was 70 years. The national incidence rate was highest among individuals aged 70–90 and substantially higher among males than females across all age groups (see table 1).

Table 1

The national incidence rate per 100 000 person-years of pleural mesothelioma for each age and sex group.

Age group (years) Male incidence rate Female incidence rate
≤40 0.02 0.02
41−50 0.67 0.17
51−60 3.30 0.63
61−70 9.48 1.53
71−80 16.84 2.16
81−90 14.13 2.22
>90 3.26 1.01

The raw age- and sex-standardized parish-to-national IRR are shown in supplementary figure B1 in appendix B, and the posterior mean of the smoothed IRR obtained from the fitted CAR model in figure 1 below. No residual autocorrelation was detected (Moran’s I statistic= -0.014, P-value=0.33).

Figure 1

Posterior mean of the smoothed parish-to-national incidence rate ratios of pleural mesothelioma in Denmark for each parish.

SJWEH-51-449-g001.tif

We found 74 and 14 parishes with smoothed incidence rates >25% and 100%, respectively, above the national with a posterior probability of >95% (see figure 2 as well as supplementary figure B2 and table B1 in appendix B). The parishes flagged with an incidence rate elevated by >100% had posterior mean smoothed IRR of 2.85–4.13 and were located in three distinct areas of Denmark around the cities of Aalborg, Odense, and Helsingør. Considering an elevated risk of >25%, more parishes in these three areas were flagged as well as one parish near Kalundborg and one in Frederikshavn; the posterior mean smoothed IRR were 1.83–4.13.

At diagnosis, individuals in our cohort had on average lived at the same address for 27 years.

Figure 2

Parishes with smoothed incidence rate ratios (IRR) >25% (a) and 100% (b) higher than the national level with a posterior probability >95%.

SJWEH-51-449-g002.tif

Discussion

We found five distinct areas in Denmark that with high certainty had an elevated risk of pleural mesothelioma. Specifically, 74 parishes in five distinct areas were flagged with an incidence rate elevated >25%, while 14 parishes in three distinct areas were flagged with smoothed incidence rates more than twice the national level. The 14 parishes were located around and in the cities of Aalborg, Odense, and Helsingør, while the 74 parishes further involved Frederikshavn and Kalundborg. All these cities previously had shipyards, and Aalborg further had a large asbestos cement factory, Odense a large producer of asbestos-containing brakes, and Kalundborg an oil refinery. Workers in such industries are of increased risk of mesothelioma (1214). It should be noted that asbestos use has, with few exceptions, been prohibited in Denmark since 1986, though the use of asbestos in brakes were not prohibited until 2004 (15).

In agreement with our results, previous studies report increased standardized IRR for male inhabitants in several Danish cities with previous shipyards and/or an asbestos cement factory with the highest ratios in Aalborg, Helsingør, and Odense (6, 16). With our choices of thresholds, no parishes were flagged in the capital area of Copenhagen, although existing studies, considering earlier time periods, have reported an increased risk (6, 7, 16). As noted by Skammeritz et al (7), the male incidence rate of mesothelioma in the capital region of Denmark seems to have stagnated since the 1980s, while incidence rates in the North Denmark region and the South Denmark region, that contain the cities Aalborg and Odense, respectively, have continued to increase up until 2009 where their study period ended (7). Since we examined the period from 1990 to 2021, our study confirmed this decreased incidence rate of mesothelioma in the capital region.

Asbestos exposure among individuals with mesothelioma has been thoroughly examined in the area of Aalborg (4, 1719). Among 122 patients seen at an occupational clinic in Aalborg, 87.7% had a known occupational exposure (18). For female patients in the North Denmark region, 75% had an identified asbestos exposure with non-occupational exposure accounting for the majority of cases (4). Additionally, increased risks of mesothelioma have been reported among individuals who as children attended schools and lived in the neighborhood of the asbestos cement factory in Aalborg (19).

In this study, mapping was based on the residential location at diagnosis. However, due to the long latency period from first asbestos exposure to development of pleural mesothelioma with a median of 38 years, the distribution at time of diagnosis does not necessarily reflect areas of asbestos exposure (20). This is evident in an Australian study where high counts of cases were seen in popular retirement areas in Perth while only few cases were reported in previous mining and milling areas that have been depopulated since the industry closed down (5). At diagnosis, individuals in our cohort had on average lived at the same address for 27 years. Note, other choices of baseline incidence rate than the national or other probability thresholds may lead to different results. In this study, we displayed the geographical heterogeneity of pleural mesothelioma risk, but underlying reasons for heterogeneity, including differentiation of occupational and environmental asbestos exposure, were not investigated.

A strength of our study is the validated data on diagnosis and parish of residence which have been retrieved from high-quality population-based registries. Furthermore, since the Danish healthcare system provides free access to health services, the risk of socioeconomic factors affecting the findings is considered low. Further, no existing study reports the risk of pleural mesothelioma at such granular level for all of Denmark and thus our study enables a more direct linkage of high-risk areas to the location of previous asbestos-using industries. In addition, our study showcases an approach to mapping rare diseases considering small geographical units and a well-known exposure-outcome pair in form of asbestos and pleural mesothelioma, and the statistical approach can be replicated for other diseases to generate hypotheses on geographically associated risk factors.

In conclusion, from a detailed mapping of pleural mesothelioma cases in Denmark, we found five distinct areas with elevated risk; all these areas could be linked to previous asbestos-using industries.

Acknowledgements

This work was supported by the Danish National Research Foundation [grant number DNRF148], Health insurance Denmark [grant number 2022-0276], a scholarship from the Novo Nordisk Foundation [NNF21SA0069373], and a scholarship from the Svend Andersen Foundation. The funders had no involvement in the study design, the collection, analysis or interpretation of the data, the writing of the article, and the decision to submit the paper for publication.

The authors declare no conflicts of interest.

References

1 

Walker-Bone K, Benke G, MacFarlane E, Klebe S, Takahashi K, Brims F et al. Incidence and mortality from malignant mesothelioma 1982-2020 and relationship with asbestos exposure: the Australian Mesothelioma Registry. Occup Environ Med 2023 Apr;80(4):186–91. [CrossRef] [PubMed]

2 

Corfiati M, Scarselli A, Binazzi A, Di Marzio D, Verardo M, Mirabelli D et al.; ReNaM Working Group. Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry. BMC Cancer 2015 Apr;15:286. [CrossRef] [PubMed]

3 

Neyens T, Lawson AB, Kirby RS, Nuyts V, Watjou K, Aregay M et al. Disease mapping of zero-excessive mesothelioma data in Flanders. Ann Epidemiol 2017 Jan;27(1):59–66.e3. [CrossRef] [PubMed]

4 

Panou V, Vyberg M, Meristoudis C, Hansen J, Bøgsted M, Omland Ø et al. Non-occupational exposure to asbestos is the main cause of malignant mesothelioma in women in North Jutland, Denmark. Scand J Work Environ Health 2019 Jan;45(1):82–9. [CrossRef] [PubMed]

5 

Cameron JK, Aitken J, Reid A, Mengersen K, Cramb S, Preston P et al. Geographic distribution of malignant mesothelioma incidence and survival in Australia. Lung Cancer 2022 May;167:17–24. [CrossRef] [PubMed]

6 

Andersson M, Olsen JH. Trend and distribution of mesothelioma in Denmark. Br J Cancer 1985 May;51(5):699–705. [CrossRef] [PubMed]

7 

Skammeritz E, Omland Ø, Hansen J, Johansen JP. Regional differences in incidence of malignant mesothelioma in Denmark. Dan Med J 2013 Mar;60(3):A4592.[PubMed]

8 

Hemminki K, Försti A, Chen T, Hemminki A. Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden. BMC Cancer 2021 Nov;21(1):1189. [CrossRef] [PubMed]

9 

Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011 Jul;39(7 Suppl):42–5. [CrossRef] [PubMed]

10 

Leroux B, Lei X, Breslow N. Estimation of Disease Rates in Small Areas: A New Mixed Model for Spatial Dependence. In: Statistical Models in Epidemiology, the Environment and Clinical Trials. Springer Verlag, New York; 2000. p. 179–91.

11 

R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2024. Available from: https://www.r-project.org/

12 

Sandén A, Järvholm B, Larsson S, Thiringer G. The risk of lung cancer and mesothelioma after cessation of asbestos exposure: a prospective cohort study of shipyard workers. Eur Respir J 1992 Mar;5(3):281–5. [CrossRef] [PubMed]

13 

Ulvestad B, Kjaerheim K, Martinsen JI, Damberg G, Wannag A, Mowe G et al. Cancer incidence among workers in the asbestos-cement producing industry in Norway. Scand J Work Environ Health 2002 Dec;28(6):411–7. [CrossRef] [PubMed]

14 

Sorahan T. Mortality of UK oil refinery and petroleum distribution workers, 1951-2003. Occup Med (Lond) 2007 May;57(3):177–85. [CrossRef] [PubMed]

15 

Fonseca AS, Jørgensen AK, Larsen BX, Moser-Johansen M, Flachs EM, Ebbehøj NE et al. Historical Asbestos Measurements in Denmark-A National Database. Int J Environ Res Public Health 2022 Jan;19(2):643. [CrossRef] [PubMed]

16 

Kjærgaard J, Michelsen EV. Malignant mesothelioma: incidence rate, survival and rate-ratio for selected municipalities for the years 1943 to 1992. Ugeskr Laeger 1997;159(31):4756–61.[PubMed]

17 

Raffn E, Lynge E, Juel K, Korsgaard B. Incidence of cancer and mortality among employees in the asbestos cement industry in Denmark. Br J Ind Med 1989 Feb;46(2):90–6. [CrossRef] [PubMed]

18 

Skammeritz E, Omland LH, Johansen JP, Omland O. Asbestos exposure and survival in malignant mesothelioma: a description of 122 consecutive cases at an occupational clinic. Int J Occup Environ Med 2011 Oct;2(4):224–36.[PubMed]

19 

Dalsgaard SB, Würtz ET, Hansen J, Røe OD, Omland Ø. Environmental asbestos exposure in childhood and risk of mesothelioma later in life: a long-term follow-up register-based cohort study. Occup Environ Med 2019 Jun;76(6):407–13. [CrossRef] [PubMed]

20 

Reid A, de Klerk NH, Magnani C, Ferrante D, Berry G, Musk AW et al. Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis. Thorax 2014 Sep;69(9):843–50. [CrossRef] [PubMed]


Additional material